Sachetta’s BioNTech BNTX Stock Holding History

Sachetta’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-59	Closed	-$6.25K	–	1083
2025 Q2	$6.25K	Hold	59	–	–	﹤0.01%	536
2025 Q1	$5.35K	Hold	59	–	–	﹤0.01%	545
2024 Q4	$6.69K	Hold	59	–	–	﹤0.01%	529
2024 Q3	$6.97K	Buy	+59	New	+$5.42K	﹤0.01%	555

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Sachetta's BNTX Position: Q3 2025 in Review

Sachetta sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 59 shares — an estimated $6.25K sold.

Sachetta first reported a position in BNTX in Q3 2024 and held it in 4 quarters. The position peaked at $6.97K in Q3 2024. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

Sachetta reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
Sachetta sold 59 BioNTech shares in Q3 2025, an estimated $6.25K.
Sachetta first reported a position in BioNTech in Q3 2024 and held it in 4 quarters.
Sachetta's BioNTech position peaked at $6.97K in Q3 2024.
254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Sachetta's 13F filing for Q3 2025, filed 24 Oct 2025.